Specificity of Anti-Histone Autoantibodies in Systemic Rheumatic Disease

Tan E.M. , 1982. Autoantibodies to nuclear antigens (ANA); their immunobiology and medicine. Advances in Immunol., 33: 167–240.

Fritzler M. J. , 1986. Autoantibody testing: Procedures and significance in systemic rheumatic diseases. Meth. Achiev. experimental Pathol., 12: 224–260.

Fritzler M. J. Tan E. M. , 1978. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J. Clin. Invest., 62: 560–567.

Rubin R. L. Joslin F. G. Tan E. M. , 1982. A solid-phase radioimmunoassay for anti-histone antibodies in human sera: Comparision with an immunofluorescence assay. Scand. J. Immunol., 15: 63–70.

Gioud M. Kaci M. Ait Monier J. C. , 1982. Histone antibodies in systemic lupus erythematosus. Arthritis Rheum., 25: 407–413.

Portanova J. P. Arndt R. E. Tan E. Kotzin B. L. , 1987. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J. Immunol., 138: 446–451.

Blomgren S. E. Condemi J. J. Vaughn J. H. , 1972. Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Am. J. Med., 52:338–348.

Gohill J. Cary P. D. Couppez M. Fritzler M. J. , 1985. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J. Immunol., 135:3116–3121.

Gohill J. Fritzler M. J. , 1987. Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1). Molec. Immunol., 24: 275–285.

Craft J. E. Radding J. A. Harding M. W. Bernstein R. M. Hardin J. A. , 1987. Autoantigenic histone epitopes; a comparision between procainamide - and hydralazine - induced lupus. Arthritis Rheum., 30: 689–694.

Muller S. Bonnier D. Thiry M. Van Regenmortel M. H. V. , Reactivity of antibodies to nucleosomes and of autoantibodies in systenic lupus erythematosus with synthetic peptides. Submitted.

Hardin J. A. Thomas J. O. , 1983. Antibodies to histones in systemic lupus erythematosus: Localization of prominent antoantigens on histones H1 and H2B. Proc. Natl. Acad. Sci. USA, 80: 7410–7414.

Costa O. Tchouassoni J. C. Tchovatcha Roux B. Monier J. C. , 1986. Anti-H1 histone antibodies in systemic lupus erythematosus: Epitope localization after immunoblotting of chymotrypsin-digested H1. Clin. Exp. Immunol. 63: 608–613.

Butler P. J. G. 1983. The folding of chromatin. CRC Critical Reviews in Biochemistry, 15: 57–91.

Thomas J. O. Wilson C. M. Hardin J. A. , 1984. The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin-sensitive regions. FEBS Lett., 169: 90–96.

Hardin J. A. , 1986. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 29: 457–460.

Portanova J. P. Arndt R. E. Kotzin B. L. , 1988. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin. J. Immunol., 140: 755–760.

Allison A. C. , 1977. Autoimmunity: Genetic, Immunology, Virology and Clinical Aspects ( Talal N. , ed.), pp. 91–139, Academic Press.

Schattner A. 1986/87. The origin of autoantibodies. Immunol. Lett., 14: 143–153.

Klinman D. M. Steinberg A. D. , 1987. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med., 165: 1755–1766.

Hannestad K. , 1969. M rheumatoid factors reacting with nitrophenyl groups and denaturated DNA. Ann. New York Acad. Sci., 168, 63.

Hannestad K. Rekvig O. P. Husebekk A. , 1981. Cross-reacting rheumatoid factors and lupus erythematosus (LE) factors. Springer Seminars in Immunopathology, 4: 133–160.

Agnello V. Arbetter A. de Kasep G. Ibanez Powell R. Tan E. M. Joslin F. , 1980. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J. Exp. Med., 151: 1514–1527.

Pasquali J. L. Azerad G. Martin T. Muller S. , 1988. The double reactivity of a human monoclonal rheumatoid factor to IgG and histones is related to distinct binding sites. Eur. J. Immunol., 18: 1127–1130.

Lafer E. M. Rauch J. Andrzejewski C. Jr Mudd D. Furie B. Furie B. Schwartz R. S. Stollar B. D. , 1981. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J. Exp. Med., 153: 897–909.

Eilat D. , 1985. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunology Today, 6: 123–127.

Stollar B. D. , 1986. Antibodies to DNA. CRC Critical Reviews in Biochemistry, 20: 1–36.

Jacob L. Lety M. A. Bach J. F. Louvard D. , 1986. Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. Proc. Natl. Acad. Sci USA, 83: 6970–6974.

André-Schwartz J. Datta S. K. Shoenfeld Y. Isenberg D. A. Stollar B. D. Schwartz R. S. , 1984. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus antibodies. Clin. Immunol. Immunopathol. 31:261.

Rekvig O. P. Hannestad K. , 1981. Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leucocytes. Scand. J. Immunol., 13: 597–604.

Rekvig O. P. Muller S. Briand J. P. Skogen B. Van Regenmortel M. H. V. , 1987. Human antinuclear autoantibodies cross-reacting with the plasma membrane and the N-terminal region of histone H2B. Immunol. Invest., 16: 535–547.

Stollar B. D. , 1985. On the nature, origin and clinical significance of anti-DNA autoantibodies. Scand. J. Rheum., 56: 22–31.

Edberg J. C. Taylor R. P. , 1986. Quantitative aspects of lupus anti-DNA autoantibody specificity. J. Immunol., 136: 4581–4587.

Isemberg D. A. Shoenfeld Y. , 1987. The origin and significance of anti DNA antibodies. Immunol. Today, 8: 279–282.

Van Regenmortel M. H. V. , 1986. Which structural features determine ptotein antigenicity? Trends in Biochemical Sciences, 11: 36–39.

Absolom D. Van Regenmortel M. H. V. , 1978. Nucleosome structure studied with purified antibodies to histones H2B, H3 and H4. FEBS Lett., 85: 61–64.

Muller S. Himmelspach K. Van Regenmortel M. H. V. , 1982. Immunochemical localization of the C-terminal hexapeptide of histone H3 at the surface of chromatin subunits. EMBO J., 1: 421–425.

Muller S. Soussanieh A. Bouley J. P. Reinbolt J. Regenmortel M. H. V. , 1983. Localization of two antigenic determinants in histone H4. Biochim. Biophys. Acta, 747: 100–106.

Muller S. Couppez M. Briand J. P. Gordon J. Sautière P. Van Regenmortel M. H. V. , 1985. Antigenic structure of histone H2B. Biochim. Biophys. Acta, 235:246.

Muller S. Plaue S. Couppez M. Van Regenmortel M. H. V. , 1986. Comparision of different methods for localizing antigenic regions in histone H2A. Molec. Immunol., 23: 593–601.

Muller S. Isabey A. Couppez M. Plaue S. Sommermeyer G. Van Regenmortel M. H. V. , 1987. Specificity of antibodies raised against triacetylated histone H4. Molec. Immunol., 24: 779–789.

Briand J. P. Muller S. Van Regenmortel M. H. V. , 1985. Synthetic peptides as antigens; Pitfalls of conjugation methods. J. Immunol. Meth., 78: 59–69.

Berzofsky J. A. , 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science, 229: 932–940.

Van Regenmortel M. H. V. , 1986. Definition of antigenicity in proteins and peptides. Protides of the Biological Fluids., 34: 81–86 (Pergamon Press).

Burnet F. M. Holmes M. C. , 1965. The natural history of the NZB/NZW F1 hybrid mouse: A laboratory model of systemic lupus erythematosus. Austral. Ann. Med., 14: 185–191.

Theofilopoulos A. N. Dixon F. J. , 1981. Etiopathogenesis of murine SLE. Immunological Rev., 55: 179–216.

Laskov R. Muller S. Hochberg M. Giloh H. Van Regenmortel M. H. V. Eilat D. , 1984. Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice. Eur. J. Immunol., 14: 74–81.

Kotzin B. L. Lafferty J. A. Portanova J. P. Rubin R. L. Tan E. M. , 1984. Monoclonal anti-histone autoantibodies derived from murine models of lupus. J. Immunol., 133: 2554–2559.

O'dell J. R. Kotzin B. L. , 1985. In vitro production of anti-histone antibodies by spleen cells from young autoantibody negative NZB/NZW mice. J. Immunol., 135: 1101–1107.

Gordon J. Kuster H. Rordorf C. , unpublished result.

Muller S. Mazen A. Martinage A. Van Regenmortel M. H. V. , 1984. Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits. EMBO J., 3: 2431–2436.

Huletsky A. de Murcis G. Muller S. Hengarther M. Lammare D. Poirier G. G. , The effect of poly (ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly (ADP-ribosyl)ation on core nucleosome structure. Submitted.

Shoenfeld Y. Isenberg D. A. Rauch J. Madaio M. P. Stollar B. D. Schwartz R. S. , 1983. Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J. Exp. Med., 158: 718–730.

Eilat D. , 1986. Anti-DNA antibodies: Problems in their study and interpretation. Clin. Exp. Immunol., 65: 215–222.

Horsfall A. C. Isenberg D. A. , 1988. Idiotypes and autoimmunity: A review of their role in human disease. J. Autoimmun., 1: 7–30.

Zouali M. Stollar B. D. Schwartz R. S. , 1988. Origini and diversification of anti-DNA antibodies. Immunol. Rev., 105: 137–159.

Stollar B. D. , 1978. Immunochemical analysis of chromosomal properties. Chapter 7: Serological analyses of histones. Methods Cell Biol., 18: 105–122 (Academic Press).

Mendelson E. Bustin M. , 1984. Monoclonal antibodies against distinct determinants of histone H5 bind to chromatin. Biochemistry, 3459–3466.

Rozalski M. Lafleur L. Ruiz-Carrillo A. , 1985. Monoclonal antibodies against histone H5. J. Biol. Chem., 260: 14379–14385.

Turner B. M. , 1982. Immunofluorescent staining of human metaphase chromosomes with monoclonal antibody to histone H2B. Chromosoma (Berl.), 87: 345–357.

Whitfield W. G. Fellows G. Turner B. M. , 1986. Characterization of monoclonal antibodies to histone 2B. Eur. J. Biochem., 157: 513–521.

Muller S. Jockers-Wretou E. Sekeris C. E. Van Regenmortel M. H. V. Bautz F. A. , 1985. Characterization of a monoclonal antibody reacting with histone H3. FEBS Lett., 182: 459–464.

Portanova J. P. Small C. J. Kohler P. F. , 1985. No demonstrable relationship between IgM and IgG antinuclear antibody levels and acetylator phenotype in patients with systemic lupus erythematosus. Arthritis Rheum., 28: 995–998.

Bernstein R. M. Hobbs R. N. Les D. J. Ward D. J. Hughes G. R. V. , 1985. Patterns of antihistone antibody specificity in systemic rheumatic disease. Arthritis Rheum., 28: 285–293.

Costa O. Monier J. C. , 1986. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. J. Rheum., 13: 722–725.

Hobbs R. N. Clayton A. L. Bernstein R. M. , 1987. Antibodies to the five histones and poly (adenosine diphosphate-ribose) in drug-induced lupus: Implications for pathogenesis. Annals of Rheum. Dis., 46: 408–416.

Shoenfeld Y. Segol G. Segol B. Neary B. Klaiman A. Stollar B. D. Isenberg D. A. , 1987. Detection of antibodies to total histones and their subtractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum., 30: 169–175.

Stetler D. A. Jacob S. T. , 1984. Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus. J. Biol. Chem., 259: 13269–13632.

Muller S. Briand J. P. Van Regenmortel M. H. V. , 1988. Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 85: 8176–8180.